The session will provide a high-level overview of the regulatory frameworks and highlight important aspects to consider when creating new healthcare solutions. We will compare the AI regulations across these two regions, emphasizing potential differences and areas where these Acts intersect or diverge. This session is designed for those involved in the development of AI tools for healthcare.
Key takeaways:
• Overview of the AI Act in Europe and its U.S. counterparts
• Key differences and similarities in regulatory requirements
• Important perspectives to consider when developing healthcare-related AI algorithms and
software solutions
MDS Finland specializes in offering regulatory, quality management, and commercialization
consulting services for medical device companies. Jani has extensive expertise in navigating the
regulatory landscape for medical devices and assisting companies in bringing their products to
market.
This webinar will be hosted by SPARK Finland.
Online via Zoom | Please register here!
Registration to the webinar is required in advance. Please register no later than 7th January 2024.Please note that you will receive the Zoom link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
